NOV 12, 2019 10:00 AM PST

Leveraging single cell copy number to resolve tumor clonality

Sponsored by: 10x Genomics
Speaker

Abstract

DATE: November 12, 2019
TIME: 10:00am PST

Direct measurement of copy number by droplet-based shallow sequencing of genomic DNA has the potential to provide new insights into tumor heterogeneity and tumor evolution. We examine its utility in a well-studied cancer cell line within a series of tumor specimens. We will demonstrate how clustering based on single cell copy number can help identify subclones that, in turn, make it possible to resolve point mutations, structural variants, and loss of heterozygosity, leading to a clearer picture of overall sample heterogeneity. We will present how we were able to gain significant novel insights—even in well-studied systems—by integrating these clone-specific variants and building models from single cell sequencing of DNA. Finally, we will discuss the design considerations, such as sequencing depth and number of cells, that were important in these studies.

 

Learning Objectives:

  • Classify cancer as a dynamic and highly heterogeneous disease composed of a mix of clones characterized by distinct genotypes
  • Recognize the limitations of bulk sequencing methods in resolving subclonal complexity
  • Describe how single cell copy number profiling, together with clustering analysis, can uncover significant hidden insights even in well studied cell lines

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
DEC 09, 2021 6:00 AM PST
C.E. CREDITS
DEC 09, 2021 6:00 AM PST
Date: December 9, 2021 Time: 6:00am (PDT), 9:00 am (EDT) As the number of biotherapeutic candidates in development is increasing, the requirements of analytical tools to understand the molec...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
NOV 12, 2019 10:00 AM PST

Leveraging single cell copy number to resolve tumor clonality

Sponsored by: 10x Genomics


Show Resources
Loading Comments...
Show Resources